Jindawei: Obtains invention patent for chondroitin fermentation production control method

Jindawei announced that the company and its subsidiaries Inner Mongolia Jindawei Pharmaceutical Co., Ltd. and Jindawei Biotechnology Co., Ltd. recently received an invention patent certificate issued by the China National Intellectual Property Administration. The invention is titled "A Control Method for Chondroitin Fermentation Production," with patent number ZL202610019817.6, authorization announcement date September 29, 2026, and a patent term of twenty years. This patent belongs to the field of chondroitin production and can effectively improve substrate conversion rate and chondroitin content in fermentation products. Its acquisition will not have a material impact on the company's production and operations, but it will help improve the intellectual property protection system and enhance core competitiveness.